Strata Critical Medical (SRTA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Strata Critical Medical (SRTA) is Neutral.

The composite score behind that read is -0.18, weighing +0.12 of bullish evidence against -0.30 bearish.

Strata Critical Medical last closed at $4.75, -1.25% on the session.

Against the IVW growth benchmark the position is -1.86% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

14 graded predictions for SRTA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Strata Critical Medical in the 33rd percentile on return on equity, where 100 is best.

Strata Critical Medical is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $425.53M.

StockMap tracks Strata Critical Medical as the 60th largest of the 80 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Neutral and 26 Moderate Underperform.

On that composite Strata Critical Medical ranks 53rd of 80 in the group, against a group median of -0.13.